New England Patriots

New England Patriots

Signal active

Investment Firm

Overview

The New England Patriots is a professional American football team based in the Greater Boston area. Its website offers products and services such as game reports, statistics, fan zone, stadium information, and community alumni information.

The company was founded in 1959 and is based in Foxboro, Massachusetts.

Highlights

Founded

1959

Industry

Sports

Employees

251-500

Investment

1

Lead Investment

0

Exits

1

Stages

Early Stage Venture

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

New England Patriots, established in 1959 and headquartered in United States, North America., specializes in Early Stage Venture investments across Biotechnology, Medical Device, Therapeutics, Sports, Venture Capital, Health Care, Pharmaceutical, Financial Services, Finance, Information Technology. The organization boasts a portfolio of 1 investments, with an average round size of $30.0M and 1 successful exits. Their recent investments include Spero Therapeutics, The Kraft Group, Atlas Venture, SR One, GlaxoSmithKline. The highest investment round they participated in was $3.0B. Among their most notable exits are Spero Therapeutics and The Kraft Group. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Tom Brady

Tom Brady

Quarterback

Investment portfolio

New England Patriots has made 1 diversity investments. Their most recent diversity investment was on Jun 08, 2015, when Spero Therapeutics raised $30.0M.

investments

1

Diversity investments

1

Lead investments

0

Number of exits

1

Investments

1

Annouced DateOrganization NameIndustryMoney Raised
Jun 08, 2015
Spero Therapeutics Spero Therapeutics
Biotechnology30.0M

Exits

1

Funding Timeline

Funding rounds

1

Investors

0

Funds

0

Funding Rounds

1

New England Patriots has raised 1 rounds. Their latest funding was raised on Jun 08, 2015 from a Series A - Spero Therapeutics round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jun 08, 2015
Series A - Spero Therapeutics Series A - Spero Therapeutics
-30.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.